AIL
VRTX icon

AGF Investments LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

AGF Investments LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.76M Buy
6,072
+2,544
+72% +$732K 0.16% 33
2022
Q2 		$994K Sell
3,528
-46
-1% -$12.3K 0.09% 66
2022
Q1 		$933K Sell
3,574
-3,241
-48% -$769K 0.08% 88
2021
Q4 		$1.5M Buy
6,815
+766
+13% +$149K 0.13% 23
2021
Q3 		$1.1M Buy
6,049
+936
+18% +$183K 0.11% 23
2021
Q2 		$1.03M Buy
5,113
+131
+3% +$27.4K 0.11% 35
2021
Q1 		$1.07M Sell
4,982
-1,693
-25% -$372K 0.13% 31
2020
Q4 		$1.58M Sell
6,675
-398
-6% -$91.3K 0.19% 21
2020
Q3 		$1.93M Sell
7,073
-2,107
-23% -$581K 0.22% 27
2020
Q2 		$2.67M Buy
9,180
+3,664
+66% +$993K 0.27% 41
2020
Q1 		$1.31M Sell
5,516
-1,518
-22% -$348K 0.17% 73
2019
Q4 		$1.54M Sell
7,034
-2,373
-25% -$480K 0.29% 90
2019
Q3 		$1.59M Sell
9,407
-132
-1% -$23.4K 0.37% 71
2019
Q2 		$1.75M Buy
9,539
+5,761
+152% +$1.01M 0.36% 85
2019
Q1 		$695K Buy
3,778
+3,001
+386% +$554K 0.16% 134
2018
Q4 		$129K Buy
777
+35
+5% +$6.06K 0.02% 372
2018
Q3 		$143K Sell
742
-885
-54% -$158K 0.02% 278
2018
Q2 		$277 Buy
+1,627
New +$252K 0.03% 270
2018
Q1 		– Sell
-136
Closed -$21K – 812
2017
Q4 		$21K Buy
136
+72
+113% +$10.7K ﹤0.01% 412
2017
Q3 		$10K Sell
64
-10
-14% -$1.5K ﹤0.01% 575
2017
Q2 		$9K Buy
+74
New +$8.91K ﹤0.01% 636

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AGF Investments LLC's VRTX Position: Q3 2022 in Review

AGF Investments LLC increased its Vertex Pharmaceuticals (VRTX) stake by 72% in Q3 2022, buying an estimated $732K and bringing the position to 6,072 shares worth $1.76M. The position accounts for 0.16% of the portfolio, ranked #33.

AGF Investments LLC first reported a position in VRTX in Q2 2017 and has held it in 21 quarters since. The position peaked at $2.67M in Q2 2020. 1,125 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • AGF Investments LLC held 6,072 shares of Vertex Pharmaceuticals worth $1.76M as of Q3 2022.
  • AGF Investments LLC bought 2,544 Vertex Pharmaceuticals shares in Q3 2022, an estimated $732K.
  • Vertex Pharmaceuticals made up 0.16% of AGF Investments LLC's portfolio in Q3 2022, its #33 holding.
  • AGF Investments LLC first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 21 quarters since.
  • AGF Investments LLC's Vertex Pharmaceuticals position peaked at $2.67M in Q2 2020.
  • 1,125 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.